Every cell within the human body contains the same DNA, but not all cells look and act alike. The key to cellular diversity lies in which genes the cells express or shut down. Cells convey this information to the appropriate machinery through epigenetic modifications. In this episode, Charlene Lancaster from The Scientist spoke with Jonathan Weissman from the Massachusetts Institute of Technology and Luke Gilbert from the University of California, San Francisco to learn about making epigenetic changes in vitro and the application of these tools in research and the clinic. The Scientist Speaks ..read more

Cloud-based systems enable remote science experiments, allowing researchers to accomplish experimental breakthroughs from virtually any location with computer access. Remote labs and cloud-connected instruments are revolutionizing the way researchers approach benchwork, improving scientific discovery and education by enabling accessible and automated workflows. In this episode, Deanna MacNeil from The Scientist spoke with Mohammed Mostajo-Radji from the University of California, Santa Cruz; Brandon Sutherland from University of Toronto’s Accelerator Consortium; and Dana Cortade from Align to I ..read more

Researchers apply the principles of synthetic biology to address some of the most pressing human health challenges. In what some consider a science and an artform, scientists use bacterial components in creative ways to create synthetic cells for cancer research. In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Kate Adamala, an assistant professor at the University of Minnesota and a synthetic biologist working on engineering synthetic cells, to learn more about the latest advances in using synthetic biology for cancer therapy applications. The Scientist S ..read more

As bioengineers incorporate smart technology into more aspects of the scientific process, these updates promise to digitize and automate laborious, repetitive research tasks while simultaneously transforming the laboratory into a more accessible and connected environment. This episode highlights cutting-edge smart technologies that allow scientists to take their research to the next level by streamlining common experimental workflows. In this month’s episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Sofie Salama and David Haussler, professors at the University of C ..read more

Fecal transplantation is an established procedure for controlling recurrent Clostridium difficile infection by replenishing healthy bacteria in the gut. Researchers explore novel applications of fecal transplantation for treating other conditions, including psychiatric disorders. In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Ian Carroll, an assistant professor in the Department of Nutrition at the University of North Carolina at Chapel Hill, and Kylie Reed, a PhD candidate in Carroll’s laboratory, to learn how the current understanding of treating infec ..read more

Xitiz Chamling is an assistant professor of ophthalmology at Johns Hopkins University School of Medicine. From vision research to the pursuit of multiple sclerosis treatments, his philosophy of science centers human-based systems to study the neuroprotective layer called myelin, which surrounds and insulates nerves cells. In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Chamling to learn more about his latest work combining stem cell and CRISPR-Cas9 technologies to break away from conventional high throughput drug screening platforms that rely on rodent ce ..read more

Disease-relevant molecules that cannot be pharmacologically targeted are sometimes referred to as undruggable, and in cancer, a number of proteins fall into this category. With innovation and new technologies, researchers make breakthroughs that turn evasive targets into druggable ones. Recent successes in establishing therapeutics against mutant oncoproteins, such as KRAS, transform the treatment landscape for patients and clinicians. A scientist who takes a unique approach to clinical trial design demonstrates how targeted small molecules are shifting drug discovery paradigms in oncology to ..read more

Jie Sun is a professor in Infectious Diseases and International Medicine at University of Virginia School of Medicine and associate director for Scientific Programs at the Carter Immunology Center. His philosophy of science prioritizes physiologically relevant infection models to tackle real-world clinical needs with research. In their latest work, Sun’s research team identified genetic and pharmacologic pathways that attenuate severe flu or COVID-19 infection and reduce blood glucose levels that spike after viral pneumonia. In this episode, Deanna MacNeil from The Scientist’s Creative Service ..read more

David Liu is a professor in the Department of Chemistry and Chemical Biology at Harvard University. Liu’s lab has introduced breakthrough technologies to the field of genome editing, including base editing and prime editing, with the aim of treating genetic diseases. In their latest work, his research team took a “no stone unturned” approach to determine a one-time base editing strategy to treat the motor neuron disease, spinal muscular atrophy (SMA). In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Liu to learn more about his philosophy of science, which ..read more

Claire Higgins is reader in the department of bioengineering at Imperial College London. Her philosophy of science involves a problem-solving approach to research, where she models tissue growth, development, and repair using human skin and hair follicles. In their latest work, her research team transplanted hair follicles into human skin scars in an attempt to make that tissue healthy again. In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Higgins to learn more about how she takes an engineering-inspired, problem-solving approach to her research. To learn ..read more